@prefix this: <https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50> .
@prefix sub: <https://pd.sciai.eu/np/2500021/RAwgNtWerb7FzNyIwHQ73hI8fhK3XlrKUWgMqE2IOcQ50/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  sub:claim a <https://pd.sciai.eu/ontology/property/Assertion>;
    <https://pd.sciai.eu/ontology/property/assertionId> "2500021"^^xsd:integer;
    <https://pd.sciai.eu/ontology/property/confidence> "0.95"^^xsd:decimal;
    <https://pd.sciai.eu/ontology/property/effectDirection> "unknown";
    <https://pd.sciai.eu/ontology/property/evidenceTier> "3"^^xsd:integer;
    <https://pd.sciai.eu/ontology/property/hasObject> <https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial>;
    <https://pd.sciai.eu/ontology/property/hasRelation> <https://pd.sciai.eu/ontology/relation/type_of>;
    <https://pd.sciai.eu/ontology/property/hasSubject> <https://pd.sciai.eu/ontology/entity/SELF%3Aexenatide%20pd3> .
  
  <https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial> a <https://pd.sciai.eu/ontology/type/Concept>;
    <http://www.w3.org/2000/01/rdf-schema#label> "Phase 3 clinical trial" .
  
  <https://pd.sciai.eu/ontology/entity/SELF%3Aexenatide%20pd3> a <https://pd.sciai.eu/ontology/type/Concept>;
    <http://www.w3.org/2000/01/rdf-schema#label> "EXENATIDE-PD3";
    <https://pd.sciai.eu/ontology/relation/type_of> <https://pd.sciai.eu/ontology/entity/CLU%3Aphase-3-clinical-trial> .
}

sub:provenance {
  sub:assertion <http://www.w3.org/2000/01/rdf-schema#comment> "Evidence-state label of the citing paper within the GLP-1 pilot corpus (207 papers; supported / contested / single-source / unlabeled), computed from cross-paper agreement over kg.assertions with author-overlap independence exclusions (v2, 2026-09-21).";
    prov:wasDerivedFrom <https://pubmed.ncbi.nlm.nih.gov/40220748/>;
    prov:wasGeneratedBy <https://sciai.eu/#sciai-lab>;
    <https://pd.sciai.eu/ontology/property/evidenceStateLabel> "single-source";
    <https://pd.sciai.eu/ontology/property/extractedAt> "2026-09-07T05:17:32.123070+00:00"^^xsd:dateTime;
    <https://pd.sciai.eu/ontology/property/extractionSchema> "universal_pd_v5";
    <https://pd.sciai.eu/ontology/property/paperType> "narrative_review";
    <https://pd.sciai.eu/ontology/property/verbatimContext> "EXENATIDE-PD3 is described as a phase 3 clinical trial testing exenatide in Parkinson’s disease." .
}

sub:pubinfo {
  this: dc:created "2026-11-06T23:32:25+00:00"^^xsd:dateTime;
    dc:creator <https://pd.sciai.eu/np/bot/sciai-kg-publisher>;
    dc:license <https://creativecommons.org/licenses/by-sa/4.0/>;
    <http://www.w3.org/2000/01/rdf-schema#comment> "Machine-generated by the sciai-lab KG publisher bot (https://pd.sciai.eu/np/bot/sciai-kg-publisher) from the sciai-lab knowledge graph (kg.assertions); not manually authored. Responsible contact: Johannes Keizer (https://orcid.org/0009-0008-6409-2596).";
    prov:wasAttributedTo <https://sciai.eu/#sciai-lab> .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAmbH3DJ0b7gHODI7sDgcVyu5oU1CCZ/ExuejhS0LiNfnjx6SFzKWZDYEvakKaDFZUNkoFzdjVVhBZfV6MKxv3Jh8xzq876JjGkFoNqIO6tUTmMtkpP2eS26/QTPuoAn4psuSIgNCvAk/98cL1wpWS9kl/WNb+1L7RL8mrN72f0P3we555ShsIRgHD8hQJM3cK/naK4JBm350q1nzfUYLhMHUriRlJyXw7JbRnpAAlKCvoIvU4a9X5XM3ULr9ochcIlw7HgZdqD/hrL6CX0c+s0huvKK9SWTkcsO1Xp4oacwUlgPVYFg7OQiyB/WOIV7iXhYlP92s0+KSqX8XJoU2jCQIDAQAB";
    npx:hasSignature "mP6kn7IT9xzAAV34CW0UH7ZdZnP8HAvNCHrx0W9O/fqHPhg1a0XVtHZCnY4oOL5uAiSlUxOEDxt2spBnyo83zH463Qz7fbAUSJXFHEs98UhzGJBexp2MVy7WXUHiQrKDrsx024hj5gJq2hPvuRukuNgxvl2/xmZ1W4yqrx2IrhQ/KUEzxzt7LVJ9O1pfcMBy4nz/0nscdlkb4/GX7u7vw849guo0K7+1Z4IVAIvcjLgNRR2zxeQi68CFfJhJAutKwg30zPkZRVQHY0Zy2oqC543gy43ssdbWDE+Cr+CusvBISL9ylbLbyjHYZVegfIyKumUZuEuSu88AWlIFyLNwZQ==";
    npx:hasSignatureTarget this:;
    npx:signedBy <https://pd.sciai.eu/np/bot/sciai-kg-publisher> .
}